Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia.
Saved in:
| Title: | Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. |
|---|---|
| Authors: | O'Brien, S. G.1 s.g.o'brien@ncl.ac.uk, Meinhardt, P.2, Bond, E.1, Beck, J.2, Peng, B.3, Dutreix, C.3, Mehring, G.3, milosavljev, S.4, Huber, C.2, Capdeville, R.3, Fischer, T.2 |
| Source: | British Journal of Cancer. 11/17/2003, Vol. 89 Issue 10, p1855-1859. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/sj.bjc.6601152 |
